Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Recent expansions of novel strategies towards the drug targeting into the brain</p>
Amit Alexander, Mukta Agrawal, A. N. M. Shofi Uddin, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 5895-5909
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Saba Naqvi, Archna Panghal, S.J.S. Flora
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 236
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, et al.
Journal of Controlled Release (2020) Vol. 327, pp. 235-265
Closed Access | Times Cited: 205
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, et al.
Journal of Controlled Release (2020) Vol. 321, pp. 372-415
Closed Access | Times Cited: 182
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
David Lee, Tamara Minko
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2049-2049
Open Access | Times Cited: 131
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
Ksenia A. Mitusova, Oleksii O. Peltek, Timofey E. Karpov, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 108
Advances in Glioblastoma Therapy: An Update on Current Approaches
Ramcharan Singh Angom, Naga Malleswara Rao Nakka, Santanu Bhattacharya
Brain Sciences (2023) Vol. 13, Iss. 11, pp. 1536-1536
Open Access | Times Cited: 74
<p>Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice</p>
Liang Kong, Xuetao Li, Yingnan Ni, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 2841-2858
Open Access | Times Cited: 106
The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders
You-Hyang Song, Jiwon Yoon, Seung‐Hee Lee
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 3, pp. 328-338
Open Access | Times Cited: 103
Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage
Amy Corbin Farr, May P. Xiong
Molecular Pharmaceutics (2020) Vol. 18, Iss. 2, pp. 593-609
Open Access | Times Cited: 102
Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design
Mukta Agrawal, Shailendra Saraf, Madhulika Pradhan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111919-111919
Open Access | Times Cited: 98
Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, et al.
Expert Opinion on Drug Delivery (2018) Vol. 15, Iss. 6, pp. 589-617
Closed Access | Times Cited: 87
Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease
Hussein Akel, Ruba Ismail, Ildikó Csóka
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 148, pp. 38-53
Closed Access | Times Cited: 85
Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential
Firda Juhairiyah, Elizabeth C. M. de Lange
The AAPS Journal (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 83
Enhancing autophagy in Alzheimer's disease through drug repositioning
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108171-108171
Closed Access | Times Cited: 69
Biomaterials in treatment of Alzheimer's disease
Mukta Agrawal, Eluri Prathyusha, Hafiz Ahmed, et al.
Neurochemistry International (2021) Vol. 145, pp. 105008-105008
Closed Access | Times Cited: 59
Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles
Alireza Poustforoosh, Mohammad Hadi Nematollahi, Hassan Hashemipour, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 777-797
Closed Access | Times Cited: 41
Access to the CNS: Strategies to overcome the BBB
Bárbara Sánchez-Dengra, Isabel González‐Álvarez, Marival Bermejo, et al.
International Journal of Pharmaceutics (2023) Vol. 636, pp. 122759-122759
Open Access | Times Cited: 32
Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood–Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery
Ahmad Khalid Madadi, Moon‐Jun Sohn
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1070-1070
Open Access | Times Cited: 10
Nose-to-brain drug delivery approach: A key to easily accessing the brain for the treatment of Alzheimer's disease
Shailendra Saraf, Amit Alexander
Neural Regeneration Research (2018) Vol. 13, Iss. 12, pp. 2102-2102
Open Access | Times Cited: 66
Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment
Thomas Adnet, Anne‐Claire Groo, Céline Picard, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 251-251
Open Access | Times Cited: 61
Non-coding RNAs in Nervous System Development and Disease
Beatrice Salvatori, Silvia Biscarini, Mariangela Morlando
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 58
Insulin mediated novel therapies for the treatment of Alzheimer's disease
Sunil Kumar Dubey, K Lakshmi, Kowthavarapu Venkata Krishna, et al.
Life Sciences (2020) Vol. 249, pp. 117540-117540
Closed Access | Times Cited: 52
Advances in dendrimer-mediated targeted drug delivery to the brain
Rahul Gauro, Mukesh Nandave, Vineet Jain, et al.
Journal of Nanoparticle Research (2021) Vol. 23, Iss. 3
Closed Access | Times Cited: 52
Nanotechnologies for intranasal drug delivery: an update of literature
Rosamaria Lombardo, Teresa Musumeci, Claudia Carbone, et al.
Pharmaceutical Development and Technology (2021) Vol. 26, Iss. 8, pp. 824-845
Closed Access | Times Cited: 52
A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
Madeleine S. A. Tan, Faraz Honarparvar, James R. Falconer, et al.
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 615-637
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top